The prostate exam is an early detection tool to prevent prostate cancer and the main diagnostic tools for obtaining signs are generally invasive. This article tries chromatographic signals from the urine of prostate cancer patients and control patients as a non-invasive examination proposal. For this purpose, methodologically, urine samples are taken, digitized in chromatograms, treated with mathematical techniques and classified. The mathematical techniques are time normalization, dead time elimination, baseline correction, noise elimination, and peak alignment. Classification techniques analyze energy, in the domain of time and frequency, and the main components in sedimentation graphs and scores. As a result, the chromatographic signal i...
Conventional screening and diagnostic procedures in prostate complaints rely on PSA (Prostate Specif...
In the present feasibility study, excitation-emission fluorescence spectroscopy has been investigate...
To assess the correlation between the clinical and molecular assays in identify early and robust pro...
The prostate exam is an early detection tool to prevent prostate cancer and the main diagnostic tool...
© 2016 IOP Publishing Ltd. Prostate cancer is one of the most common cancers. Serum prostate-specifi...
Prostate cancer is a widespread form of cancer that affects patients globally and is challenging to ...
Prostate cancer is the second most common cause of cancer death among men. It is an asymptomatic and...
Prostate cancer (PC) – refers to important and serious problems in urology. In Ukraine, PC ranks fou...
Cancer is the second leading cause of death worldwide, and deaths from cancer worldwide are projecte...
Prostate cancer diagnostic algorithm Aim: The aim of the study is to implement the latest scientific...
Prostate cancer (PCa) is the most commonly diagnosed cancer in male individuals, principally affecti...
Background/Aim: Prostate cancer (PCa) diagnosis using patient urine samples represents a non-invasiv...
Objective: To avoid over-treatment of low-risk prostate cancer patients, it is important to identify...
Prostate cancer is the most detected cancer in males and one of the leading causes of cancer mortali...
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the dis...
Conventional screening and diagnostic procedures in prostate complaints rely on PSA (Prostate Specif...
In the present feasibility study, excitation-emission fluorescence spectroscopy has been investigate...
To assess the correlation between the clinical and molecular assays in identify early and robust pro...
The prostate exam is an early detection tool to prevent prostate cancer and the main diagnostic tool...
© 2016 IOP Publishing Ltd. Prostate cancer is one of the most common cancers. Serum prostate-specifi...
Prostate cancer is a widespread form of cancer that affects patients globally and is challenging to ...
Prostate cancer is the second most common cause of cancer death among men. It is an asymptomatic and...
Prostate cancer (PC) – refers to important and serious problems in urology. In Ukraine, PC ranks fou...
Cancer is the second leading cause of death worldwide, and deaths from cancer worldwide are projecte...
Prostate cancer diagnostic algorithm Aim: The aim of the study is to implement the latest scientific...
Prostate cancer (PCa) is the most commonly diagnosed cancer in male individuals, principally affecti...
Background/Aim: Prostate cancer (PCa) diagnosis using patient urine samples represents a non-invasiv...
Objective: To avoid over-treatment of low-risk prostate cancer patients, it is important to identify...
Prostate cancer is the most detected cancer in males and one of the leading causes of cancer mortali...
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the dis...
Conventional screening and diagnostic procedures in prostate complaints rely on PSA (Prostate Specif...
In the present feasibility study, excitation-emission fluorescence spectroscopy has been investigate...
To assess the correlation between the clinical and molecular assays in identify early and robust pro...